1 May 2018Americas

LSPN North America: Are trade secrets an effective method of protecting inventions?

Innovators are being encouraged to research the benefits of using trade secrets as an effective method of protecting inventions.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

LSPN North America: Modest activity for Patents 4 Patients scheme, says USPTO

27 April 2018 The Patents 4 Patients programme has received a modest amount of activity since it started two years ago, according to Mary Till, senior legal advisor at the US Patent and Trademark Office.

LSPN North America 2018: Optimism over UPC despite delays

26 April 2018 Panellists discussing global patent enforceability at the Life Sciences Patent Network North America event have expressed optimism over the Unified Patent Court (UPC), despite uncertainty about its implementation.

More on this story

LSPN North America: Modest activity for Patents 4 Patients scheme, says USPTO

27 April 2018 The Patents 4 Patients programme has received a modest amount of activity since it started two years ago, according to Mary Till, senior legal advisor at the US Patent and Trademark Office.

LSPN North America 2018: Optimism over UPC despite delays

26 April 2018 Panellists discussing global patent enforceability at the Life Sciences Patent Network North America event have expressed optimism over the Unified Patent Court (UPC), despite uncertainty about its implementation.

More on this story

LSPN North America: Modest activity for Patents 4 Patients scheme, says USPTO

27 April 2018 The Patents 4 Patients programme has received a modest amount of activity since it started two years ago, according to Mary Till, senior legal advisor at the US Patent and Trademark Office.

LSPN North America 2018: Optimism over UPC despite delays

26 April 2018 Panellists discussing global patent enforceability at the Life Sciences Patent Network North America event have expressed optimism over the Unified Patent Court (UPC), despite uncertainty about its implementation.

More features

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?

Broad Institute wins appeal to restore CRISPR patent in Europe

BMS faces fresh lawsuit over alleged cancer drug monopoly

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

Boies Schiller Flexner adds three-strong litigation team